Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

362.95
Delayed Data
As of Jan 18
 -0.29 / -0.08%
Today’s Change
325.35
Today|||52-Week Range
484.57
-1.13%
Year-to-Date
Jacobs & Co Buys Praxair Inc, Procter & Gamble Co, Bristol-Myers Squibb Company, Sell...
Jan 18 / GuruFocus News - Paid Partner Content
Company News for January 09, 2017
Jan 09 / Zacks.com - Paid Partner Content
Prentiss Smith & Co Inc Buys Unilever PLC, Vodafone Group PLC, Verizon Communications...
Jan 18 / GuruFocus News - Paid Partner Content
The FDA Approved Fewer Drugs in 2016: Here's Why
Jan 09 / Zacks.com - Paid Partner Content
5 Biotech Stocks You'll Want to Watch in the 1st Quarter
Jan 18 / MotleyFool.com - Paid Partner Content
2 Top Stocks in Biotech
Jan 09 / MotleyFool.com - Paid Partner Content
Key FDA Events to Watch Out for in Q1
Jan 17 / Zacks.com - Paid Partner Content
Why Biotech Titans Are Clashing Over Cholesterol
Jan 08 / MotleyFool.com - Paid Partner Content
Drugmakers alarmed by Trump pricing threat
Jan 14 / FT.com - Paid Partner Content
Top Stocks to Buy in 2017
Jan 07 / MotleyFool.com - Paid Partner Content
Sanofi confident it can overturn Praluent patent ruling
Jan 12 / FT.com - Paid Partner Content
Better Buy: Regeneron Pharmaceuticals, Inc. vs. Pfizer
Jan 07 / MotleyFool.com - Paid Partner Content
Stock Market News for January 11, 2017
Jan 11 / Zacks.com - Paid Partner Content
Roche's (RHHBY) Lucentis Gets FDA Nod for Fifth Indication
Jan 06 / Zacks.com - Paid Partner Content
Biotech Stock Roundup: ARIAD to be Acquired for $5.2B, Vertex Outlook Falls Short
Jan 11 / Zacks.com - Paid Partner Content
Regeneron shares tumble as US court blocks cholesterol drug
Jan 06 / FT.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Clovis Oncology, Pfizer, Roche's, Sanofi and Regen...
Jan 10 / Zacks.com - Paid Partner Content
Amgen's Repatha Wins Over Sanofi & Regeneron's Praluent
Jan 06 / Zacks.com - Paid Partner Content
Amgen Inks Multiple Deals, Offers Update on Repatha Lawsuit
Jan 10 / Zacks.com - Paid Partner Content
Obama's final jobs report; Trump hits Toyota; Indian GDP forecast
Jan 06 / CNNMoney.com
Biotech Resolutions: More Innovation, Better Execution, and Fewer Price Hikes
Jan 10 / MotleyFool.com - Paid Partner Content
Healthcare Stocks to Buy for 2017: Less Risky, More Risky, and Most Risky
Jan 05 / MotleyFool.com - Paid Partner Content
The 10 Worst Stocks in the Nasdaq in 2016
Jan 09 / MotleyFool.com - Paid Partner Content